Research Papers

25 of 164048 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Pathological and molecular characteristics of inflammatory breast cancer.
Di Bonito M; Cantile M; Botti G.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans-…
Tseng TS; Gross T; Celestin MD; Dang W; Young L; Kao YH; Li M; Smith DL; Bok LR; Fuloria J; Moody-Thomas S.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Assessing patient navigation as a tool to address equity in cancer early detection.
Brown J; Kaufman RE; Ariail M; Williams DL.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.
Park JY; Luu HN; Park HY; Lin HY; Radlein S; Di Pietro G; Yeo CD; Kim SJ; Kang N; Antwi S; Sexton WJ; Spiess PE; Dickinson S; Parker A.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
The effect of metabolic risk factors on cancer mortality among blacks and whites.
Yoshida Y; Schmaltz CL; Jackson-Thompson J; Simoes EJ.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor recep…
Yeo CD; Kim IK; Ban WH; Kang HS; Kim JW; Kim SJ; Park JY; Lee SH.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Association between breast cancer risk and leisure physical activity in a rural cohort population.
Stahr SD; Runnells GA; Rogers LJ; McElfish PA; Kadlubar SA; Su LJ.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Family health history of colorectal cancer: a structural equation model of factors influencing Chinese Americans' commu…
Yeh YL; Li M; Kwok OM; Chen LS.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Association between smoking and neutrophil to lymphocyte ratio among prostate cancer survivors: the National Health and…
Kao YH; Lin WT; Thomas CL; Lin HY; Tseng TS.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Individual- and county-level determinants of high breast cancer incidence rates.
Schootman M; Ratnapradipa K; Loux T; McVay A; Su LJ; Nelson E; Kadlubar S.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Population science in cancer.
Lin HY; Tseng TS.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical app…
Mulazzani L; Alvisi M.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Adjuvant treatment in biliary tract cancer.
Palloni A; Frega G; De Lorenzo S; Rizzo A; Abbati F; Deserti M; Tavolari S; Brandi G.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Cholangiocarcinoma: the quest for a second-line systemic treatment.
Vienot A; Neuzillet C.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
The future is now: beyond first line systemic therapy in hepatocellular carcinoma.
Nenu I; Breaban I; Pascalau S; Bora CN; Stefanescu H.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Surgical management of hepatocellular carcinoma-Western versus Eastern attitude.
Neri F; Maroni L; Ravaioli M.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular ca…
Ruzzenente A; De Angelis M; Conci S; Campagnaro T; Isa G; Bagante F; Ciangherotti A; Pedrazzani C; Capelli P; Iacono C; Guglielmi A.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs.
Serio I; Napoli L; Leoni S; Piscaglia F.
Transl Cancer Res (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.
Listì A; Barraco N; Bono M; Insalaco L; Castellana L; Cutaia S; Ricciardi MR; Gristina V; Bronte E; Pantuso G; Passiglia F.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer.
Vavalà T; Mariniello A; Novello S.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
EGFR first- and second-generation TKIs-there is still place for them in <i>EGFR</i>-mutant NSCLC patients.
Karachaliou N; Fernandez-Bruno M; Bracht JWP; Rosell R.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Finocchiaro CY; Rota A; Barbieri V; Bettini A; Bianco R; Borra G; Buffoni L; Bulotta A; Carta A; Cortinovis D; Costanzo R; Cusmai A; Danesi R; D'Argento E; Del Conte A; Franchina T; Gilli M; Gregorc V; Irtelli L; Landi L; Malorgio F; Mancuso G; Martelli O; Mazzanti P; Melotti B; Migliorino MR; Minotti V; Montrone M; Morabito A; Roca E; Romano G; Rossi A; Savio G; Tiseo M; Boscardini I; Piccolo L; Pilotto S; Malapelle U.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted t…
Mayo de Las Casas C; Garzón-Ibañez M; Jordana-Ariza N; Viteri-Ramírez S; Moya-Horno I; Karachaliou N; Yeste Z; Campos R; Villatoro S; Balada-Bel A; García-Peláez B; Reguart N; Teixidó C; Jantús E; Calabuig S; Aguado C; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Catalán MJ; Bertrán-Alamillo J; García-Román S; Rodriguez S; Alonso L; Aldeguer E; Martínez-Bueno A; González-Cao M; Aguilar Hernandez A; Garcia-Mosquera J; de Los Llanos Gil M; Fernandez M; Rosell R; Molina-Vila MÁ.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
Targeted therapy and non-small cell lung cancer: a new era!
Malapelle U; Rolfo C.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared
PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient.
Yu Z; Zhang P; Gu W; Jiang X.
Unknown Journal
Published: 2019
2/6 Transparent
Funding Declared